Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CTKB NASDAQ:LAB NYSE:OWLT NYSE:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTKBCytek Biosciences$3.64+1.1%$3.29$2.37▼$7.63$455.97M1.34933,205 shs1.54 million shsLABStandard BioTools$1.30-2.3%$1.21$0.92▼$2.32$505.16M1.321.54 million shs1.51 million shsOWLTOwlet$7.39+1.2%$7.37$2.75▼$9.74$120.63M1.887,686 shs36,560 shsSENSSenseonics$0.49+0.8%$0.52$0.25▼$1.40$319.78M0.928.49 million shs3.44 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTKBCytek Biosciences+1.11%-1.36%+0.83%-5.70%-45.75%LABStandard BioTools-2.26%-7.14%-5.11%+8.33%-41.96%OWLTOwlet+0.97%-9.99%-10.86%+84.52%+67.95%SENSSenseonics+0.78%-11.53%-0.24%-31.15%+15.23%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTKBCytek Biosciences2.344 of 5 stars3.12.00.00.02.24.20.0LABStandard BioTools3.3857 of 5 stars3.53.00.00.03.63.30.6OWLTOwlet3.5549 of 5 stars3.73.00.00.03.14.20.6SENSSenseonics1.6234 of 5 stars3.82.00.00.00.60.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTKBCytek Biosciences 2.20Hold$5.6053.85% UpsideLABStandard BioTools 3.00Buy$2.5092.31% UpsideOWLTOwlet 3.33Buy$10.2538.70% UpsideSENSSenseonics 3.50Strong Buy$1.55217.10% UpsideCurrent Analyst Ratings BreakdownLatest OWLT, LAB, CTKB, and SENS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025SENSSenseonicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/15/2025SENSSenseonicsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.257/9/2025OWLTOwletNorthland SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$12.007/8/2025SENSSenseonicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$1.10 ➝ $1.406/2/2025SENSSenseonicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$1.105/28/2025CTKBCytek BiosciencesMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$9.00 ➝ $7.005/12/2025CTKBCytek BiosciencesThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$3.50 ➝ $3.005/9/2025CTKBCytek BiosciencesTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$4.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTKBCytek Biosciences$200.45M2.30$0.04 per share103.74$3.07 per share1.19LABStandard BioTools$174.43M2.83N/AN/A$1.27 per share1.02OWLTOwlet$78.10M1.56$0.32 per share23.04($1.86) per share-3.97SENSSenseonics$23.68M13.50N/AN/A$0.07 per share6.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTKBCytek Biosciences-$6.02M-$0.09N/A∞N/A-5.71%-2.90%-2.30%8/6/2025 (Estimated)LABStandard BioTools-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%8/11/2025 (Estimated)OWLTOwlet-$12.54M-$1.43N/A43.47N/A-15.28%-0.36%0.20%8/7/2025 (Estimated)SENSSenseonics-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/ALatest OWLT, LAB, CTKB, and SENS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025LABStandard BioTools-$0.04N/AN/AN/A$39.83 millionN/A8/7/2025Q2 2025OWLTOwlet-$0.21N/AN/AN/A$22.17 millionN/A8/6/2025Q2 2025CTKBCytek Biosciences-$0.02N/AN/AN/A$46.03 millionN/A5/8/2025Q1 2025CTKBCytek Biosciences-$0.04-$0.09-$0.05-$0.09$43.18 million$41.46 million5/8/2025Q1 2025OWLTOwlet-$0.05-$0.07-$0.02$0.11$18.14 million$21.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTKBCytek BiosciencesN/AN/AN/AN/AN/ALABStandard BioToolsN/AN/AN/AN/AN/AOWLTOwletN/AN/AN/AN/AN/ASENSSenseonicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTKBCytek BiosciencesN/A5.624.95LABStandard BioToolsN/A6.125.37OWLTOwletN/A1.190.90SENSSenseonics59.172.472.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTKBCytek Biosciences69.46%LABStandard BioTools53.74%OWLTOwlet72.60%SENSSenseonics12.36%Insider OwnershipCompanyInsider OwnershipCTKBCytek Biosciences10.33%LABStandard BioTools23.16%OWLTOwlet67.07%SENSSenseonics4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTKBCytek Biosciences500126.66 million113.58 millionOptionableLABStandard BioTools620379.82 million291.86 millionOptionableOWLTOwlet10616.52 million5.44 millionNo DataSENSSenseonics90654.22 million573.90 millionN/AOWLT, LAB, CTKB, and SENS HeadlinesRecent News About These CompaniesSenseonics (NYSE:SENS) Upgraded to "Strong-Buy" at Lake Street CapitalJuly 19, 2025 | marketbeat.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call ...July 16, 2025 | gurufocus.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern TimeJuly 16, 2025 | globenewswire.comBrokers Set Expectations for Senseonics FY2027 EarningsJuly 16, 2025 | marketbeat.comSequel Med Tech expects full twiist launch in the fallJuly 15, 2025 | drugdeliverybusiness.comDSenseonics (NYSE:SENS) Now Covered by Analysts at TD CowenJuly 15, 2025 | marketbeat.comFY2028 EPS Estimates for Senseonics Boosted by HC WainwrightJuly 15, 2025 | marketbeat.comFY2026 EPS Estimates for Senseonics Raised by HC WainwrightJuly 10, 2025 | marketbeat.comNew glucose sensors, insulin patch pumps lead ADA’s Scientific SessionsJuly 3, 2025 | medtechdive.comMADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensorsJune 24, 2025 | medtechdive.comMSenseonics lays out hopes for next-gen CGM commercial timelinesJune 24, 2025 | drugdeliverybusiness.comDHere's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 WeeksJune 18, 2025 | zacks.comSenseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with DiabetesJune 4, 2025 | globenewswire.comSenseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott LaboratoriesMay 21, 2025 | quiverquant.comQSenseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private PlacementMay 21, 2025 | globenewswire.comRevisiting Senseonics After 4 Years: Still A Big Investment OpportunityMay 21, 2025 | seekingalpha.comSenseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics opens $50M public offering, $25M private placement with AbbottMay 15, 2025 | drugdeliverybusiness.comDSenseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics Holdings, Inc. (AMEX:SENS) Q1 2025 Earnings Call TranscriptMay 9, 2025 | msn.comSenseonics Holdings, Inc. Reports First Quarter Financial ResultsMay 9, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesRocket Lab: A Parabolic Run Meets a Healthy PullbackBy Ryan Hasson | July 23, 2025View Rocket Lab: A Parabolic Run Meets a Healthy PullbackThe Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to WatchRocket Lab Gets New Street-High Price Target from Citi By Ryan Hasson | July 16, 2025View Rocket Lab Gets New Street-High Price Target from Citi D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?By Nathan Reiff | July 28, 2025View D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?Why Abbott Laboratories Is a Q2 2025 Buy: Growth & YieldBy Thomas Hughes | July 18, 2025View Why Abbott Laboratories Is a Q2 2025 Buy: Growth & YieldOWLT, LAB, CTKB, and SENS Company DescriptionsCytek Biosciences NASDAQ:CTKB$3.64 +0.04 (+1.11%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.64 -0.01 (-0.14%) As of 08/1/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Standard BioTools NASDAQ:LAB$1.30 -0.03 (-2.26%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.30 -0.01 (-0.38%) As of 08/1/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Owlet NYSE:OWLT$7.39 +0.09 (+1.23%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$7.39 0.00 (0.00%) As of 08/1/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, oxygen, activity, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.Senseonics NYSE:SENS$0.49 +0.00 (+0.78%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.49 +0.00 (+0.45%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
